Skip to main content

Obesity, diet, & lifestyle interventions


Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.


Highlights

Syringe and pills

11-01-2022 | SGLT2 inhibitors | News

Real-world adjunctive medication outcomes in type 1 diabetes revealed

People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.

Doctor measures a man's waist

10-10-2022 | Semaglutide | News

STEP 5: Sustained semaglutide treatment maintains weight loss

The substantial weight loss achieved with weekly semaglutide 2.4 mg is maintained if people continue to take the medication for 2 years, show the STEP 5 results.

Senior women working out using dumbells

08-09-2022 | Older adults | News

Lifestyle intervention strategy beneficial for older adults with diabetes

Lifestyle intervention proves “highly successful” in adults with diabetes aged 65 to 85 years, improving both metabolic and functional health, report researchers.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox